Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 175 (RN7SKP175) is annotated as a pseudogene of the RN7SK gene in the human genome [3][5]. Pseudogenes are genetic sequences that resemble known genes but typically contain mutations or alterations (such as insertions, deletions, or premature stop codons) that prevent them from producing functional proteins or RNA products [7]. While some pseudogenes have been shown to play regulatory roles, the majority—including RN7SKP175—are not catalogued as functional or as therapeutic targets [3][5][7]. RN7SKP175 itself has no known functional product and is not implicated in recognized biological functions, pathologies, or therapeutic interactions. The canonical functional form, RN7SK, is a non-coding RNA that modulates transcription by interacting with transcription factors and RNA polymerase II and is implicated in cellular differentiation, proliferation, and immune response [1][2][4][6]. However, RN7SKP175 does not encode functional RNA and there are no data describing any biological functions or disease associations for this pseudogene [3][5][7]. No drugs, biomarkers, or therapeutically relevant mechanisms have been identified for RN7SKP175 [3][5]. This entry is a pseudogene and not a functional target; it is not appropriate for use as a canonical therapeutic target or active biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 175 (RN7SKP175).